The role of pharmacokinetics in bioequivalence of studies of inhalation drugs
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Presentation
- By: HOCHHAUS, Guenther (University of Florida, Pharmaceutics, Gainesville, United States of America)
I. Background: Demonstrating the bioequivalence of inhaltion drugs is a challenge. Currently in vitro, pharmacokinetic and pharmacodynamic clinical studies are employed with european (EMA) and north-american (FDA) differing significantly 2. Aims: Aim of this presentation is it to discuss advantages and disadvantages of above methods. 3. Methods:.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.